Course1

(Day 1, Panel 1) Impacts of AI’s Rapid Rise in the Life Sciences

$115.00
  • Instructor(s):  BCLT

2nd BCLT's Advanced Patent Law Institute (Day 1, Panel 1) Impacts of AI’s Rapid Rise in the Life Sciences Occurred May 21, 2024 Event Information | Agenda | Resources Topical questions to speakers can be sent via their firm biopages or LinkedIn profiles hyperlinked within the agenda and slide deck. Rapid advancement in life sciences technologies has made keeping up with the legal implications more important than ever.  Join us for the 2nd BCLT Advanced Life Sciences Institute, where you will learn from the experts about cutting-edge issues impacting your life sciences practice. Our programming will share key insights and best practices related to the rapid rise of AI in the life sciences and new trends for licensing, deals, and life sciences funding models. We will also have experts reviewing key developments in the law (Section 112, obviousness-type double patenting), anti-counterfeiting and patient safety, and the ever-complex interplay of regulatory and IP exclusivities.  Finally, don’t miss our in-depth discussions on future pandemic preparedness and use of trade secrets v. patents for portfolio protection!   Speakers: Michelle Chen, In Silico Hans Sauer, BIO AJ Tibbetts, Greenberg Traurig

  • On-Demand
    Format
  • 60
    Min.
  • 11/1/25
    Avail. to
  • DETAILS
Course1

(Day 1, Panel 3) Life Sciences Funding Models and Mechanisms

$50.00
  • Instructor(s):  BCLT

2nd BCLT's Advanced Patent Law Institute (Day 1, Panel 3) Life Sciences Funding Models and MechanismsOccurred May 21, 2024 Event Information | Agenda | Resources Topical questions to speakers can be sent via their firm biopages or LinkedIn profiles hyperlinked within the agenda and slide deck. Rapid advancement in life sciences technologies has made keeping up with the legal implications more important than ever.  Join us for the 2nd BCLT Advanced Life Sciences Institute, where you will learn from the experts about cutting-edge issues impacting your life sciences practice. Our programming will share key insights and best practices related to the rapid rise of AI in the life sciences and new trends for licensing, deals, and life sciences funding models. We will also have experts reviewing key developments in the law (Section 112, obviousness-type double patenting), anti-counterfeiting and patient safety, and the ever-complex interplay of regulatory and IP exclusivities.  Finally, don’t miss our in-depth discussions on future pandemic preparedness and use of trade secrets v. patents for portfolio protection!   Speakers: Paul Billings, Biological Dynamics Vern Norviel, WSGR

  • On-Demand
    Format
  • 38
    Min.
  • 11/1/25
    Avail. to
  • DETAILS
Course1

Biotechnology & Inventorship – What You Need To Know | Transactions and Inventorship: Best Practices for Diligence and Covenants (Part 3)

$115.00
  • Instructor(s):  BCLT

Part 3: Transactions and Inventorship: Best Practices for Diligence and Covenants In part three, Transactions and Inventorship: Best Practices for Diligence and Covenants, join BCLT Life Sciences Director Allison Schmitt in conversation with Brent Sokol, an experienced biotech litigator, and Prashant Girinath, a top life sciences patent strategist. We examine the law of inventorship, recommend best practices for transaction readiness and diligence, and provide case examples in which an inventorship dispute impacted a commercial transaction.

  • On-Demand
    Format
  • 70
    Min.
  • 4/4/25
    Avail. to
  • DETAILS
Course1

Fireside chat with Paul Grewal, Chief Legal Officer at Coinbase

FREE
  • Instructor(s):  BCLT

This program does not offer MCLE. Welcome to the first episode of Blockchain at Law at Berkeley. We are a student initiated and student run organization at UC Berkeley School of Law that works on educating and supporting the next generation of lawyers on all things blockchain and cryptocurrency. My name is Yi Qu and together with Sidhant Raghuvanshi (Class of 2023), on February the 7th, 2024, we met with Paul Grewal, the Chief Legal Officer at Coinbase. We sat down with him in a classroom on campus and talked about the recent Bitcoin ETF approval, Coinbase's investment in artificial intelligence, whether Paul has a favorite regulator outside of this country, and why he thinks more law students should tune into this episode.   Speaker: Paul Grewal, Coinbase

  • On-Demand
    Format
  • 20
    Min.
  • 11/1/25
    Avail. to
  • DETAILS
Course1

Minority Interest, Major Impact: Considerations When Non-US Investors Invest in US Companies

$50.00
  • Instructor(s):  BCLT & Baker McKenzie

Event Information | Resources | Speaker Bios & Contact Info Cross-border investments in the tech sector fit squarely into US regulators' focus on national security.  And with so many potentially protected technologies--including those that appear to be dual use--how can companies properly handle foreign investment in this highly-scrutinized environment?  What are the traps? Join us to hear from a fascinating pair of lawyers--one from the corporate side and one from the national security side.   Speakers: Aarthi Belani, Baker McKenzie Rod Hunter, Baker McKenzie

  • On-Demand
    Format
  • 32
    Min.
  • 5/1/26
    Avail. to
  • DETAILS
Course1

Stock Based Compensation (SBC) Managing Unforeseen Foreign Tax Issues

FREE
  • Instructor(s):  BCLT & Baker McKenzie

Event Information | Resources | Speaker Bio & Contact Info   Tech companies face significant cross-border tax issues due to stock based compensation. Employee mobility and significant use of international operations have escalated the urgency of addressing these tax issues sooner rather than later. Typical corporate events, including IPOs, M&A, and share buybacks, threaten tech companies with significant, unnecessary taxes without proper planning. This program addresses hot topics in SBC compensation.   Have topical Questions? Contact the speakers directly!   Speakers: Gene Tien, Baker McKenzie Consulting LLC, Palo Alto Himali Patel, Baker McKenzie, Palo Alto

  • Webcast
    Format
  • 27
    Min.
  • 2/4/25
    Presented
  • DETAILS